Clinical Trials Logo

Clinical Trial Summary

The aim of this non-interventional study is to extend the knowledge on effectiveness of Ovaleap® (number of oocytes and pregnancy rate) during routine IVF- or ICSI-treatment using a Gonadotropin-releasing hormone (GnRH) antagonist protocol in a large number of patients.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02809989
Study type Observational
Source Teva Branded Pharmaceutical Products R&D, Inc.
Contact
Status Completed
Phase
Start date March 31, 2016
Completion date March 13, 2018

See also
  Status Clinical Trial Phase
Completed NCT05721495 - Deferred Embryo Transfer in an In Vitro Program With Single Embryo Transfer Policy N/A
Not yet recruiting NCT02099916 - Administration of DHEA in Patients With Poor Response to Ovarian Stimulation for IVF Phase 2/Phase 3
Not yet recruiting NCT05173038 - Second Ejaculate and IUI
Completed NCT04619914 - the Effect of Clomiphene Citrate Plus Estradiol Valerate Versus Letrozole on Endometrial Thickness and Pregnancy Rate in Infertile Women N/A
Enrolling by invitation NCT03579550 - Hysteroscopic Metroplasty in Unexplained Infertile Women With Dysmorphic Uterus N/A
Recruiting NCT04389203 - Pregnancy Rate After Unilateral Tubal Disconnection N/A
Not yet recruiting NCT00542126 - Luteal-Phase GnRH Agonist Administration in Frozen-Thawed IVF Embryo Transfer Cycles N/A
Not yet recruiting NCT05467852 - Didroxyprogesterone Promotes Natural Pregnancy in Infertile Patients With Endometriosis Phase 3
Recruiting NCT01933009 - The Effect of GnRH Administration During Luteal Support in Frozen-thawed Transfer Cycles N/A
Recruiting NCT01933126 - Intrauterine Injection of HCG and Implantation Rate N/A
Completed NCT04500743 - Role of Suppression of Endometriosis With Progestins Before IVF-ET N/A